ArticleDiabetes2013

β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice.

Mark C Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.